← Back to headlines
Hims & Hers Stock Falls After FDA Advisors Snub First Peptide
Shares of Hims & Hers declined following a decision by FDA advisors regarding the company's first peptide product.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
Related Stories
Daily News and Photography Digest Aggregates Global Headlines for September 2, 2026
32m ago
Ford Ramps Up Pickup Truck Production Despite August Sales Decline
36m ago
Chevron to Invest $7 Billion to Double Venezuela Oil Output
41m ago
Kennedy Center Begins Removal of Outdoor ‘Blue’ Sculpture Amid Political Pressure
47m ago